Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and safety of SARS-CoV-2 (COVID-19 virus) vaccine in liver transplant recipients
TCTR20210526004Completed
- Sponsor
- Faculty of Medicine, Chulalongkorn University
- Start
- Jun 2021
- Countries
- 1
01
Overview
Open-label, single-arm trial in coronavirus disease 2019 (COVID-19), sponsored by Faculty of Medicine, Chulalongkorn University. Primary endpoints: Immunogenicity of SARS-CoV-2 vaccine and Safety of SARS-CoV-2 vaccine. Started Jun 2021; status: completed.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20210526004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210526004.